BlackRock Investment Management, LLC - TENAX THERAPEUTICS INC ownership

TENAX THERAPEUTICS INC's ticker is TENX and the CUSIP is 88032L100. A total of 38 filers reported holding TENAX THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of TENAX THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$8,000
-20.0%
4,3180.0%0.00%
Q3 2016$10,000
-9.1%
4,3180.0%0.00%
Q2 2016$11,000
+37.5%
4,318
+13.6%
0.00%
Q1 2016$8,000
-33.3%
3,8020.0%0.00%
Q4 2015$12,000
+9.1%
3,802
+7.6%
0.00%
Q3 2015$11,000
-15.4%
3,5340.0%0.00%
Q2 2015$13,0000.0%3,534
-12.7%
0.00%
Q1 2015$13,000
-18.8%
4,0480.0%0.00%
Q4 2014$16,0000.0%4,0480.0%0.00%
Q3 2014$16,0004,0480.00%
Other shareholders
TENAX THERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,108,593$3,636,0001.53%
ARMISTICE CAPITAL, LLC 990,000$3,247,0001.16%
RA Capital Management 2,389,700$7,838,0000.78%
Opaleye Management Inc. 540,000$1,771,0000.74%
SABBY MANAGEMENT, LLC 2,693,537$8,835,0000.49%
Broadfin Capital, LLC 1,968,631$6,457,0000.40%
DAFNA Capital Management LLC 79,509$261,0000.23%
BOURGEON CAPITAL MANAGEMENT LLC 55,500$182,0000.12%
BAILARD, INC. 60,000$197,0000.09%
Verition Fund Management LLC 32,140$105,0000.02%
View complete list of TENAX THERAPEUTICS INC shareholders